Year |
Citation |
Score |
2023 |
Boulay A, Trabanelli S, Boireau S, Boyer-Clavel M, Nisole S, Romero P, Jandus C, Beignon AS, Arhel NJ. Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models. Immunohorizons. 7: 243-255. PMID 37000496 DOI: 10.4049/immunohorizons.2300007 |
0.336 |
|
2022 |
Martin MF, Maarifi G, Abiven H, Seffals M, Mouchet N, Beck C, Bodet C, Lévèque N, Arhel NJ, Blanchet FP, Simonin Y, Nisole S. Usutu Virus escapes langerin-induced restriction to productively infect human Langerhans cells, unlike West Nile virus. Emerging Microbes & Infections. 11: 761-774. PMID 35191820 DOI: 10.1080/22221751.2022.2045875 |
0.31 |
|
2021 |
Maarifi G, Lagisquet J, Hertel Q, Bonaventure B, Chamontin C, Fuchs K, Moncorgé O, Tauziet M, Mombled M, Papin L, Molès JP, Bodet C, Lévèque N, Gross A, Arhel N, ... Nisole S, et al. Alarmin S100A9 restricts retroviral infection by limiting reverse transcription in human dendritic cells. The Embo Journal. e106540. PMID 34121210 DOI: 10.15252/embj.2020106540 |
0.447 |
|
2020 |
Clé M, Desmetz C, Barthelemy J, Martin MF, Constant O, Maarifi G, Foulongne V, Bolloré K, Glasson Y, De Bock F, Blaquiere M, Dehouck L, Pirot N, Tuaillon E, Nisole S, et al. Zika Virus Infection Promotes Local Inflammation, Cell Adhesion Molecule Upregulation, and Leukocyte Recruitment at the Blood-Brain Barrier. Mbio. 11. PMID 32753493 DOI: 10.1128/Mbio.01183-20 |
0.359 |
|
2020 |
Sa Ribero M, Jouvenet N, Dreux M, Nisole S. Interplay between SARS-CoV-2 and the type I interferon response. Plos Pathogens. 16: e1008737. PMID 32726355 DOI: 10.1371/Journal.Ppat.1008737 |
0.359 |
|
2020 |
Maillet S, Fernandez J, Decourcelle M, El Koulali K, Blanchet FP, Arhel NJ, Maarifi G, Nisole S. Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner. Viruses. 12. PMID 32545337 DOI: 10.3390/V12060636 |
0.514 |
|
2020 |
Martin MF, Nisole S. West Nile Virus Restriction in Mosquito and Human Cells: A Virus under Confinement. Vaccines. 8. PMID 32485916 DOI: 10.3390/Vaccines8020256 |
0.359 |
|
2020 |
Burette M, Allombert J, Lambou K, Maarifi G, Nisole S, Di Russo Case E, Blanchet FP, Hassen-Khodja C, Cabantous S, Samuel J, Martinez E, Bonazzi M. Modulation of innate immune signaling by a eukaryotic-like effector protein. Proceedings of the National Academy of Sciences of the United States of America. 117: 13708-13718. PMID 32482853 DOI: 10.1073/Pnas.1914892117 |
0.366 |
|
2019 |
Maarifi G, Smith N, Maillet S, Moncorgé O, Chamontin C, Edouard J, Sohm F, Blanchet FP, Herbeuval JP, Lutfalla G, Levraud JP, Arhel NJ, Nisole S. TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells. Science Advances. 5: eaax3511. PMID 31799391 DOI: 10.1126/Sciadv.Aax3511 |
0.385 |
|
2019 |
Fernandez J, Machado AK, Lyonnais S, Chamontin C, Gärtner K, Léger T, Henriquet C, Garcia C, Portilho DM, Pugnière M, Chaloin L, Muriaux D, Yamauchi Y, Blaise M, Nisole S, et al. Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating. Nature Microbiology. PMID 31611641 DOI: 10.1038/S41564-019-0575-6 |
0.548 |
|
2019 |
Maarifi G, Czubala MA, Lagisquet J, Ivory MO, Fuchs K, Papin L, Birchall JC, Nisole S, Piguet V, Blanchet FP. Langerin (CD207) represents a novel interferon-stimulated gene in Langerhans cells. Cellular & Molecular Immunology. PMID 31607745 DOI: 10.1038/S41423-019-0302-5 |
0.471 |
|
2019 |
Smith N, Rodero MP, Bekaddour N, Bondet V, Ruiz-Blanco YB, Harms M, Mayer B, Badder-Meunier B, Quartier P, Bodemer C, Baudouin V, Dieudonné Y, Kirchhoff F, Sanchez Garcia E, Charbit B, ... ... Nisole S, et al. Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment. Science Advances. 5: eaav9019. PMID 31309143 DOI: 10.1126/Sciadv.Aav9019 |
0.383 |
|
2019 |
Nisole S, Fernandez J, Maarifi G, Arhel NJ. [SUMO regulates the capacity of TRIM5α to inhibit HIV-1]. Medecine Sciences : M/S. 35: 106-109. PMID 30774075 DOI: 10.1051/Medsci/2019016 |
0.477 |
|
2017 |
Lucas-Hourani M, Dauzonne D, Munier-Lehmann H, Khiar S, Nisole S, Dairou J, Helynck O, Afonso PV, Tangy F, Vidalain PO. An original chemical series of pyrimidine biosynthesis inhibitors that boost the antiviral interferon response. Antimicrobial Agents and Chemotherapy. PMID 28807907 DOI: 10.1128/Aac.00383-17 |
0.315 |
|
2017 |
Khiar S, Lucas-Hourani M, Nisole S, Smith N, Helynck O, Bourgine M, Ruffié C, Herbeuval JP, Munier-Lehmann H, Tangy F, Vidalain PO. Identification of a small molecule that primes the type I interferon response to cytosolic DNA. Scientific Reports. 7: 2561. PMID 28566766 DOI: 10.1038/S41598-017-02776-Z |
0.323 |
|
2017 |
Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, Dy M, Scott-Algara D, Manoury B, Zirafi O, McCort-Tranchepain I, Durroux T, Bachelerie F, Schwartz O, Münch J, ... ... Nisole S, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nature Communications. 8: 14253. PMID 28181493 DOI: 10.1038/Ncomms14253 |
0.382 |
|
2016 |
Maillet S, Nisole S. Daxx, a broad-spectrum viral restriction factor. Virologie (Montrouge, France). 20: 261-272. PMID 32260023 DOI: 10.1684/Vir.2016.0667 |
0.415 |
|
2016 |
Smith N, Vidalain PO, Nisole S, Herbeuval JP. An efficient method for gene silencing in human primary plasmacytoid dendritic cells: silencing of the TLR7/IRF-7 pathway as a proof of concept. Scientific Reports. 6: 29891. PMID 27412723 DOI: 10.1038/Srep29891 |
0.356 |
|
2016 |
Maarifi G, Hannoun Z, Geoffroy MC, El Asmi F, Zarrouk K, Nisole S, Blondel D, Chelbi-Alix MK. MxA mediates SUMO-induced resistance to Vesicular Stomatitis Virus. Journal of Virology. PMID 27170750 DOI: 10.1128/Jvi.00722-16 |
0.437 |
|
2015 |
Portilho DM, Fernandez J, Ringeard M, Machado AK, Boulay A, Mayer M, Müller-Trutwin M, Beignon AS, Kirchhoff F, Nisole S, Arhel NJ. Endogenous TRIM5α Function Is Regulated by SUMOylation and Nuclear Sequestration for Efficient Innate Sensing in Dendritic Cells. Cell Reports. PMID 26748714 DOI: 10.1016/J.Celrep.2015.12.039 |
0.387 |
|
2015 |
Dutrieux J, Maarifi G, Portilho DM, Arhel NJ, Chelbi-Alix MK, Nisole S. PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx. Plos Pathogens. 11: e1005280. PMID 26566030 DOI: 10.1371/Journal.Ppat.1005280 |
0.469 |
|
2015 |
Maarifi G, Maroui MA, Dutrieux J, Dianoux L, Nisole S, Chelbi-Alix MK. Small Ubiquitin-like Modifier Alters IFN Response. Journal of Immunology (Baltimore, Md. : 1950). 195: 2312-24. PMID 26223657 DOI: 10.4049/Jimmunol.1500035 |
0.341 |
|
2015 |
Blondel D, Maarifi G, Nisole S, Chelbi-Alix MK. Resistance to Rhabdoviridae Infection and Subversion of Antiviral Responses. Viruses. 7: 3675-702. PMID 26198243 DOI: 10.3390/V7072794 |
0.397 |
|
2015 |
Dutrieux J, Portilho DM, Arhel NJ, Hazan U, Nisole S. TRIM5α is a SUMO substrate. Retrovirology. 12: 28. PMID 25880753 DOI: 10.1186/S12977-015-0155-7 |
0.306 |
|
2015 |
Brantis-de-Carvalho CE, Maarifi G, Gonçalves Boldrin PE, Zanelli CF, Nisole S, Chelbi-Alix MK, Valentini SR. MxA interacts with and is modified by the SUMOylation machinery. Experimental Cell Research. 330: 151-63. PMID 25447205 DOI: 10.1016/J.Yexcr.2014.10.020 |
0.376 |
|
2015 |
Dutrieux J, Maarifi G, Portilho DM, Arhel NN, Chelbi-Alix MK, Nisole S. ID: 26: PML-dependent inhibition of HIV-1 reverse-transcription by Daxx Cytokine. 76: 68. DOI: 10.1016/J.Cyto.2015.08.056 |
0.511 |
|
2015 |
Maarifi G, Maroui MA, Dianoux L, Nisole S, Chelbi-Alix MK. ID: 23: SUMO3 alters IFN responses by impairing it capacity to enhance PML protein expression Cytokine. 76: 68. DOI: 10.1016/J.Cyto.2015.08.053 |
0.376 |
|
2015 |
Maarifi G, Maroui MA, Dutrieux J, Dianoux L, Nisole S, Chelbi-Alix MK. ID: 22: Reduction by SUMO of interferon gamma, but not alpha, transcriptional response Cytokine. 76: 67. DOI: 10.1016/J.Cyto.2015.08.052 |
0.338 |
|
2014 |
Zebboudj A, Maroui MA, Dutrieux J, Touil-Boukoffa C, Bourouba M, Chelbi-Alix MK, Nisole S. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells. Biochimie. 107: 247-56. PMID 25241256 DOI: 10.1016/J.Biochi.2014.09.002 |
0.386 |
|
2014 |
Maroui MA, El Asmi F, Dutrieux J, Chelbi-Alix MK, Nisole S. [Implication of PML nuclear bodies in intrinsic and innate immunity]. MéDecine Sciences : M/S. 30: 765-71. PMID 25174753 DOI: 10.1051/Medsci/20143008014 |
0.368 |
|
2014 |
Maarifi G, Chelbi-Alix MK, Nisole S. PML control of cytokine signaling. Cytokine & Growth Factor Reviews. 25: 551-61. PMID 24861946 DOI: 10.1016/J.Cytogfr.2014.04.008 |
0.333 |
|
2014 |
El Asmi F, Maroui MA, Dutrieux J, Blondel D, Nisole S, Chelbi-Alix MK. Implication of PMLIV in both intrinsic and innate immunity. Plos Pathogens. 10: e1003975. PMID 24586174 DOI: 10.1371/Journal.Ppat.1003975 |
0.38 |
|
2013 |
Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK. Differential Roles of PML Isoforms. Frontiers in Oncology. 3: 125. PMID 23734343 DOI: 10.3389/Fonc.2013.00125 |
0.314 |
|
2012 |
Roesch F, Meziane O, Kula A, Nisole S, Porrot F, Anderson I, Mammano F, Fassati A, Marcello A, Benkirane M, Schwartz O. Hyperthermia stimulates HIV-1 replication. Plos Pathogens. 8: e1002792. PMID 22807676 DOI: 10.1371/Journal.Ppat.1002792 |
0.52 |
|
2012 |
Nunzio FD, Félix T, Arhel NJ, Nisole S, Charneau P, Beignon A. HIV-derived vectors for therapy and vaccination against HIV. Vaccine. 30: 2499-2509. PMID 22342915 DOI: 10.1016/J.Vaccine.2012.01.089 |
0.474 |
|
2012 |
Asmi FE, Geagea H, Nondier I, Blondel D, Nisole S, Chelbi-Alix MK. P108 PMLIV inhibits VSV replication through the specific induction of IFN-beta and IFN-lambda Cytokine. 59: 554. DOI: 10.1016/J.Cyto.2012.06.199 |
0.444 |
|
2011 |
Maudet C, Bertrand M, Le Rouzic E, Lahouassa H, Ayinde D, Nisole S, Goujon C, Cimarelli A, Margottin-Goguet F, Transy C. Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways. The Journal of Biological Chemistry. 286: 23742-52. PMID 21566118 DOI: 10.1074/Jbc.M111.220780 |
0.491 |
|
2009 |
Bergamaschi A, David A, Le Rouzic E, Nisole S, Barré-Sinoussi F, Pancino G. The CDK inhibitor p21Cip1/WAF1 is induced by FcγR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages Journal of Virology. 83: 12253-12265. PMID 19759136 DOI: 10.1128/Jvi.01395-09 |
0.525 |
|
2009 |
Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, Margottin-Goguet F, Mothes W, Hazan U, Transy C, Pancino G, Nisole S. Human TRIM gene expression in response to interferons. Plos One. 4: e4894. PMID 19290053 DOI: 10.1371/Journal.Pone.0004894 |
0.403 |
|
2009 |
Bergamaschi A, Ayinde D, David A, Le Rouzic E, Morel M, Collin G, Descamps D, Damond F, Brun-Vezinet F, Nisole S, Margottin-Goguet F, Pancino G, Transy C. The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. Journal of Virology. 83: 4854-60. PMID 19264781 DOI: 10.1128/Jvi.00187-09 |
0.537 |
|
2009 |
Maudet C, Rouzic EL, Bertrand M, Ayinde D, Nisole S, Margottin-Goguet F, Transy C. HIV-1 VPR impairs cell growth through the inactivation of two genetically distinct host cell proteins Retrovirology. 6: 57. DOI: 10.1186/1742-4690-6-S2-P57 |
0.49 |
|
2009 |
Bergamaschi A, David A, Le Rouzic E, Nisole S, Barré-Sinoussi F, Pancino G. The CDK inhibitor p21Cip1/WAF1 is induced by FcγR activation and restricts HIV-1 replication in human macrophages Retrovirology. 6: P11. DOI: 10.1186/1742-4690-6-S2-P11 |
0.514 |
|
2009 |
Ayinde D, Bergamaschi A, David A, Le Rouzic E, Morel M, Nisole S, Margottin-Goguet F, Pancino G, Transy C. The HIV-2 Vpx protein usurps the Cul4A-DDB1-DCAF1 ubiquitin ligase to overcome a post-entry block in macrophage infection Retrovirology. 6. DOI: 10.1186/1742-4690-6-S2-O16 |
0.551 |
|
2008 |
Arhel NJ, Nisole S, Carthagena L, Coutant F, Souque P, Brussel A, Estaquier J, Charneau P. Lack of endogenous TRIM5alpha-mediated restriction in rhesus macaque dendritic cells. Blood. 112: 3772-6. PMID 18703703 DOI: 10.1182/Blood-2008-04-151761 |
0.54 |
|
2008 |
Carthagena L, Parise MC, Ringeard M, Chelbi-Alix MK, Hazan U, Nisole S. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities. Retrovirology. 5: 59. PMID 18613956 DOI: 10.1186/1742-4690-5-59 |
0.411 |
|
2006 |
Delcroix-Genête D, Quan PL, Roger MG, Hazan U, Nisole S, Rousseau C. Antiviral properties of two trimeric recombinant gp41 proteins. Retrovirology. 3: 16. PMID 16515685 DOI: 10.1186/1742-4690-3-16 |
0.372 |
|
2005 |
Nisole S, Stoye JP, Saïb A. TRIM family proteins: retroviral restriction and antiviral defence. Nature Reviews. Microbiology. 3: 799-808. PMID 16175175 DOI: 10.1038/Nrmicro1248 |
0.363 |
|
2005 |
Yap MW, Nisole S, Stoye JP. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Current Biology : Cb. 15: 73-8. PMID 15649369 DOI: 10.1016/J.Cub.2004.12.042 |
0.459 |
|
2004 |
Nisole S, Lynch C, Stoye JP, Yap MW. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1 Proceedings of the National Academy of Sciences of the United States of America. 101: 13324-13328. PMID 15326303 DOI: 10.1073/Pnas.0404640101 |
0.537 |
|
2004 |
Yap MW, Nisole S, Lynch C, Stoye JP. Trim5α protein restricts both HIV-1 and murine leukemia virus Proceedings of the National Academy of Sciences of the United States of America. 101: 10786-10791. PMID 15249690 DOI: 10.1073/Pnas.0402876101 |
0.518 |
|
2004 |
Nisole S, Saïb A. Early steps of retrovirus replicative cycle. Retrovirology. 1: 9. PMID 15169567 DOI: 10.1186/1742-4690-1-9 |
0.405 |
|
2002 |
Said EA, Krust B, Nisole S, Svab J, Briand JP, Hovanessian AG. The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor. The Journal of Biological Chemistry. 277: 37492-502. PMID 12147681 DOI: 10.1074/Jbc.M201194200 |
0.711 |
|
2002 |
Nisole S, Krust B, Hovanessian AG. Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Experimental Cell Research. 276: 155-73. PMID 12027446 DOI: 10.1006/Excr.2002.5522 |
0.673 |
|
2002 |
Nisole S, Said EA, Mische C, Prevost MC, Krust B, Bouvet P, Bianco A, Briand JP, Hovanessian AG. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. The Journal of Biological Chemistry. 277: 20877-86. PMID 11919179 DOI: 10.1074/Jbc.M110024200 |
0.735 |
|
2001 |
Callebaut C, Nisole S, Briand JP, Krust B, Hovanessian AG. Inhibition of HIV infection by the cytokine midkine. Virology. 281: 248-64. PMID 11277697 DOI: 10.1006/Viro.2000.0767 |
0.693 |
|
2001 |
Hovanessian AG, Puvion-Dutilleul F, Nisole S, Svab J, Perret E, Deng JS, Krust B. The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Experimental Cell Research. 261: 312-28. PMID 11112338 DOI: 10.1006/Excr.2000.5071 |
0.595 |
|
2000 |
Nisole S, Krust B, Dam E, Bianco A, Seddiki N, Loaec S, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG. The HB-19 pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits attachment of T lymophocyte- and macrophage-tropic HIV to permissive cells. Aids Research and Human Retroviruses. 16: 237-49. PMID 10710212 DOI: 10.1089/088922200309331 |
0.677 |
|
1999 |
Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. The Journal of Biological Chemistry. 274: 27875-84. PMID 10488134 DOI: 10.1074/Jbc.274.39.27875 |
0.707 |
|
1999 |
Seddiki N, Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG. The V3 loop-mimicking pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits HIV infection in primary macrophage cultures. Aids Research and Human Retroviruses. 15: 381-90. PMID 10082122 DOI: 10.1089/088922299311358 |
0.687 |
|
1998 |
Dumonceaux J, Nisole S, Chanel C, Quivet L, Amara A, Baleux F, Briand P, Hazan U. Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. Journal of Virology. 72: 512-9. PMID 9420253 DOI: 10.1128/Jvi.72.1.512-519.1998 |
0.457 |
|
Show low-probability matches. |